Provided by Tiger Fintech (Singapore) Pte. Ltd.

AstraZeneca PLC

71.13
-0.6800-0.95%
Post-market: 71.05-0.0790-0.11%19:39 EDT
Volume:2.73M
Turnover:193.59M
Market Cap:220.60B
PE:28.63
High:71.15
Open:70.99
Low:70.50
Close:71.81
Loading ...

AstraZeneca Says Camizestrant Combo Shows Benefit in Advanced Breast Cancer Phase 3 Trial

MT Newswires Live
·
02 Jun

AstraZeneca (AZN) Gets a Buy from J.P. Morgan

TIPRANKS
·
02 Jun

AstraZeneca announces results from MATTERHORN Phase III trial of IMFINZI

TIPRANKS
·
02 Jun

New Hope for Strokes And Heart Attacks -- Barron's

Dow Jones
·
31 May

AstraZeneca PLC Stock Rises Friday, Outperforms Market

Dow Jones
·
31 May

Danaher, AstraZeneca Collaborate on Precision Medicine

MT Newswires Live
·
30 May

Heart Disease Could Be a Goner When These New Drugs Arrive -- Barrons.com

Dow Jones
·
29 May

AstraZeneca PLC Stock Falls Wednesday, Underperforms Market

Dow Jones
·
29 May

AstraZeneca (AZN) Gets a Buy from Goldman Sachs

TIPRANKS
·
28 May

Guggenheim Keeps Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
27 May

AstraZeneca PLC Stock Rises Monday, Underperforms Market

Dow Jones
·
27 May

AstraZeneca’s Financial Health at Risk: Navigating Geopolitical and Economic Challenges

TIPRANKS
·
26 May

AstraZeneca (AZN) Receives a Buy from Leerink Partners

TIPRANKS
·
25 May

AstraZeneca PLC Stock Rises Friday, Outperforms Market

Dow Jones
·
24 May

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-05-23

Reuters
·
23 May

Astrazeneca's Imfinzi Gets Expanded EU Committee Recommendation to Include Muscle Invasive Bladder Cancer

MT Newswires Live
·
23 May

Strokes and Heart Attacks Kill. New Drugs Are Coming to Prevent Them. -- Barrons.com

Dow Jones
·
23 May

Barclays Keeps Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
23 May

A 5-star fund manager is capitalizing on Trump's global market shake-up. Here's how.

Dow Jones
·
23 May

AstraZeneca PLC Stock Rises Wednesday, Outperforms Market

Dow Jones
·
22 May